CCK and neoplasm: By investigating these potential mechanisms, we discovered new insights on how blocking the CCK-BR signaling pathway aids in remodeling the tumor microenvironment, the activity of T-cells, and the modulation of the gut microbiome to enhance the efficacy of immune checkpoint therapy.